Table 2 Level of comorbidity (total cohort)
| Â | Observation | Intervention | Total | |||
|---|---|---|---|---|---|---|
# | % | # | % | # | % | |
Eligible for CMA | 35 | 97.2 | 29 | 80.6 | 64 | 88.9 |
Medication/polypharmacy | ||||||
 3+ Medications | 29 | 80.6 | 21 | 58.3 | 50 | 69.4 |
 C, D or X Medication interaction | 23 | 63.9 | 19 | 52.8 | 42 | 58.3 |
Hospital Admissions in the last 12 months | ||||||
 None | 20 | 55.6 | 28 | 77.8 | 48 | 66.7 |
 One | 9 | 25.0 | 4 | 11.1 | 13 | 18.1 |
 Two or more | 7 | 19.4 | 3 | 8.3 | 10 | 13.9 |
Health impact on Activities of Daily Life (Four most prevalent) | ||||||
 Gets short of breath walking on flat surfaces | 8 | 22.2 | 6 | 16.7 | 14 | 19.4 |
 Needs to stay in bed or a chair most of the day | 11 | 30.6 | 1 | 2.8 | 12 | 16.7 |
 Has difficulty taking long walks | 10 | 27.8 | 1 | 2.8 | 11 | 15.3 |
 One or more falls or near falls in past 6 months | 5 | 13.9 | 4 | 11.1 | 9 | 12.5 |
Health impact on Quality of Life | ||||||
 Ability to work or do other daily activities | 14 | 38.9 | 5 | 13.9 | 19 | 26.4 |
 Ability to do hobbies | 12 | 33.3 | 5 | 13.9 | 17 | 23.6 |
 Social life | 13 | 36.1 | 3 | 8.3 | 16 | 22.2 |
 Family life | 10 | 27.8 | 2 | 5.6 | 12 | 16.7 |